US Corporate Board Director Changes SEC Filings — October 02, 2026

02-10-2026

ChronoScale Holdings Corporation (NASDAQ: CHRN) announced two new AI infrastructure customer agreements that, together with existing contracts, are expected to drive annualized revenue run-rate to $1 billion by calendar Q3 2027. The company also completed the sale of its Ekso Bionics business unit to sharpen focus on its core accelerated compute and AI infrastructure business. While the new agreements signal strong demand, the company cautioned that achieving the contracted revenue is subject to risks including timely deployment, power availability, and access to capital.

• · The two new agreements include a contract extension with an existing AI infrastructure customer and a separate agreement with a new customer.
• · ChronoScale was formed through the strategic combination of Applied Digital’s cloud business and EKSO Bionics Holdings, Inc.
• · The company's strategy focuses on delivering scalable accelerated computing capacity for large-scale AI deployments.
• · The forward-looking statements caution that actual results could vary materially due to risks such as the ability to raise capital, customer concentration, and slower-than-expected industry growth.

02-10-2026

Hines Global Income Trust (HGIT) announced a leadership transition effective January 1, 2027: Adam Hines will join Laura Hines-Pierce as Co-CEO, David Steinbach becomes President, Alfonso Munk becomes Global CIO, and Jeff Hines becomes Chairman. Laura will also replace Jeff as CEO and Chair of HGIT, with Adam joining its Board. The discretionary business has grown at approximately 20% CAGR since 2018, and the Private Wealth business has doubled in size. However, the filing does not provide any financial metrics for HGIT itself, and the transition is a planned succession rather than a response to performance issues.

• · Leadership changes effective January 1, 2027.
• · Laura Hines-Pierce has been Co-CEO for over five years.
• · David Steinbach will be the firm's first President.
• · Jeff Hines will become Chairman and step back from day-to-day management.
• · An independent External Advisory Board will be established with no governance authority; Investment Committee authority unchanged.
• · Hines has 4,600 employees in 29 countries and manages approximately $91B in assets (as of June 30, 2026).
• · Private Wealth business has doubled in size under Adam Hines' vision.

02-10-2026

Hyliion Holdings Corp. (HYLN) adopted a Nonqualified Deferred Compensation Plan on September 28, 2026, allowing select management, highly compensated employees, and non-employee directors to defer settlement of restricted stock unit and performance share awards. The plan is designed to comply with Section 409A of the Internal Revenue Code and will be administered by the Compensation Committee, with initial enrollment expected in December 2026. This is a routine compensatory arrangement with no immediate financial impact or material change to the company's operations.

• · The plan is unfunded and does not provide for company contributions.
• · Deferral elections for performance-based awards may be made no later than six months before the end of the applicable performance period.
• · Distributions can be made as in-service, retirement, or change-in-control distributions, with installment options ranging from 1 to 10 annual payments.
• · Upon a participant's death before payment commencement, the account is paid to beneficiaries in a lump sum.
• · The plan permits 409A-compliant hardship distributions.

02-10-2026

Seritage Growth Properties (SRG-PA) announced the departure of Eric Dinenberg as Chief Operating Officer, effective September 30, 2026, following a mutually agreed extension of his previously established separation date. He will receive severance and other amounts per his employment agreements, subject to a release of claims, and will provide consulting services to the company post-separation.

• · Eric Dinenberg's employment ended on September 30, 2026, under the terms of his Amended and Restated Employment Offer Letter Addendum dated October 23, 2023, as amended on November 21, 2025.
• · The separation date was extended from September 15, 2026 to September 30, 2026 by mutual agreement.
• · Mr. Dinenberg will provide consulting services to the Company after the separation date.
• · Severance is contingent upon execution and non-revocation of a general release of claims.

02-10-2026

United States Antimony Corp (UAMY) announced a permanent CFO appointment and the termination of its prior CFO. Shawn P. Winkler, previously Interim CFO, was appointed Senior Vice President and CFO effective September 30, 2026, replacing Richard R. Isaak, whose employment was terminated without cause. Mr. Winkler brings significant investment banking and energy-industry CFO experience.

• · Mr. Winkler previously spent 15 years as an investment banker at BMO Capital Markets and Deutsche Bank Securities, advising on over $10 billion in M&A transactions in the natural resources sector.
• · He has an MBA from Rice University’s Jones Graduate School of Management and a BA from Rice University.
• · No family relationships or reportable transactions exist between Mr. Winkler and the Company.

02-10-2026

Quince Therapeutics announced the conditional resignation of three directors (June Bray, David Lamond, Christopher Senner) effective upon stockholder approval of key proposals at a Special Meeting on October 6, 2026. The board conditionally appointed four new directors (Catherine Bonuccelli, Leone Patterson, James Valentine, Drayton Wise) to take effect at the same time, with committee assignments. The resignations were not due to any disagreement with the company.

• · The Special Meeting of Stockholders is scheduled for October 6, 2026.
• · The resignations are conditional upon stockholder approval of three proposals: Conversion Proposal, Minimum Price Proposal, and Authorized Shares Proposal.
• · The Authorized Shares Proposal seeks to increase authorized common stock from 250,000,000 to 275,000,000 shares.
• · The resigning directors' decisions were not due to any disagreement with the company.
• · Incoming directors will serve on specific committees: Bonuccelli (Audit, Compensation), Patterson (Audit Chair, Compensation Chair), Valentine (Audit, Nominating & Corp Gov Chair), Wise (Nominating & Corp Gov).
• · Leone Patterson is a Certified Public Accountant (inactive).
• · James Valentine previously worked at the U.S. FDA.
• · Drayton Wise led the global launch of ARIKAYCE at Insmed.

02-10-2026

Hayward Holdings, Inc. appointed Jared Arrowood as Chief Accounting Officer and principal accounting officer, effective October 1, 2026. Eifion Jones, the CFO, ceased serving as principal accounting officer but remains CFO and principal financial officer. Mr. Arrowood's compensation includes a $300,000 base salary, a 35% target cash bonus, and a $120,000 long-term incentive equity award.

• · Jared Arrowood, age 42, joined Hayward in August 2023 as Assistant Corporate Controller and was promoted to Vice President, Corporate Controller in July 2024.
• · Prior to Hayward, Arrowood served in finance leadership roles at SPX FLOW, Inc., most recently as Vice President of Finance, Mixing Solutions.
• · Arrowood has entered into the company's standard form of indemnification agreement for directors and officers.
• · No arrangements or understandings exist between Arrowood and any other person regarding his appointment, and no family relationships with any director or executive officer.

02-10-2026

FiEE, Inc. appointed Angel Colon to its Board of Directors effective September 30, 2026, filling the vacancy created by the resignation of David Natan. Mr. Colon will also serve as chairperson of the Audit Committee and as a member of the Nominating and Corporate Governance and Compensation Committees. He will receive a cash fee of $12,500 per quarter for his service as a director.

• · Mr. Colon is 52 years old and has served as Managing Director of NY Capital Management Group, LLC and Turing Funds, LLC since 2017.
• · He previously served as Managing Director of Entoro Capital LLC and Entoro Securities, LLC from 2019 to 2025.
• · Mr. Colon currently serves as an Independent Director of Sentage Holdings Inc. (Nasdaq: SNTG), Horizon Space Acquisition I Corp. (OTCMKTS: HSPO), and Netclass Technology Inc (Nasdaq: NTCL).
• · The Board determined Mr. Colon is independent under SEC and Nasdaq rules, qualifies as an 'audit committee financial expert', and meets enhanced independence requirements for compensation committee members.
• · No arrangements or understandings exist between Mr. Colon and any other person regarding his selection as a director, and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K were identified.

02-10-2026

Rimini Street, Inc. granted equity awards to EVP and Chief Revenue Officer Steven Hershkowitz to restore forfeited unvested awards after his reinstatement. The awards include 210,084 stock options, 233,180 RSUs, and 32,258 PSUs, all with an exercise price of $4.29 per share. This is a compensatory arrangement with no financial results or performance metrics disclosed.

• · Options vest over 1-3 years with various schedules; RSUs vest over 1-3 years; PSUs tied to 2026 adjusted EBITDA and revenue goals.
• · Options have a 10-year term from October 1, 2026.
• · PSUs are subject to performance conditions per the 2026 LTI Plan, with service-based vesting after earning.

02-10-2026

American Coastal Insurance Corporation announced the resignation of Christopher Griffith as Chief Operating Officer and Chief Information Officer, effective October 1, 2026, to pursue another opportunity. The departure was disclosed in an SEC Form 8-K filed on October 2, 2026, and signed by President & CEO B. Bradford Martz. No replacement or interim appointment was announced in the filing.

• · Resignation effective date: October 1, 2026
• · Filing date: October 2, 2026
• · Mr. Griffith held dual roles as COO and CIO
• · No successor or interim appointment disclosed

02-10-2026

Golden Minerals Company announced the appointment of Keith Laskowski as Executive Vice President of Exploration and Barbara Henderson as Corporate Secretary, effective October 1, 2026. Additionally, David Watkins has assumed the role of President and CEO following the resignation of Pablo Castanos from his positions as President, CEO, and Director, effective September 30, 2026. The board thanked Mr. Castanos for his service and improvements to the company's financial position, while expressing confidence in the new leadership team to drive future growth.

• · Keith Laskowski holds an MSc in Geology from the Colorado School of Mines (1987) and has been a registered Qualified Person with the Mining and Metallurgical Society of America since 2006.
• · Barbara Henderson holds a B.Sc. in Earth Sciences from the University of Waterloo and an M.Sc. in Economic Geology from the University of Alberta, and is a registered Professional Geologist.
• · Golden Minerals holds a 67% majority control in the Desierto 1 & 2 concessions and a 51% joint venture interest in the Sarita Este concession in Argentina, and a 60% interest in the Sand Canyon project in Nevada.

02-10-2026

On September 28, 2026, Jon McGarity resigned from the Board of Greenland Mines Ltd. (formerly Klotho Neurosciences, Inc.), and the Board appointed Peter Love and Blair Jordan as new directors to fill the vacancies. The resignations were not due to any disagreement with the company. The appointments bring mineral exploration and corporate finance expertise (Love) and public company executive, investment banking, and legal experience (Jordan) to the board.

• · Peter Love, age 47, has over 18 years of experience in mineral exploration and corporate finance; he is Executive Chairman and co-founder of Torino Metals.
• · Blair Jordan, age 57, is CEO and director of Tungsten Reserve Corp. and independent director and Audit Committee Chair of Standard Uranium Ltd.
• · Blair Jordan previously led a restructuring at Forum Markets, Inc. and completed a $425 million private placement for its Ethereum treasury strategy.
• · Neither Love nor Jordan has been appointed to any Board committees, has family relationships with company officers, or has any reportable transactions under Item 404(a).
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

02-10-2026

Amentum Holdings, Inc. disclosed an amendment and restatement of Executive Chair Steven J. Demetriou's employment agreement, effective September 28, 2026. The new agreement sets a base salary of $625,000, a bonus/short-term incentive of 100% of base salary, and a long-term incentive target value at grant of $1,250,000. The agreement removes severance obligations but provides for a pro-rata bonus and full accelerated vesting of outstanding LTI awards upon termination.

• · Initial term of the employment agreement ended on September 27, 2026; the agreement now continues until terminated by the Company or Mr. Demetriou.
• · No severance obligations, except for pro-rata bonus and full accelerated vesting of outstanding LTI awards.

02-10-2026

Prothena Corporation plc announced that Chad J. Swanson, Ph.D., Chief Development Officer, will resign effective October 9, 2026, to join a strategic partner and lead a program partnered with Prothena. The departure is amicable and related to a business relationship, with no financial terms disclosed.

• · Dr. Swanson's resignation is effective October 9, 2026.
• · He will assume a leadership role over a program partnered with Prothena at the strategic partner.
• · No successor has been announced.

02-10-2026

John B. Sanfilippo & Son, Inc. (JBSS) completed its previously announced leadership transition on October 1, 2026. Jeffrey T. Sanfilippo moved from CEO to Executive Chair, Jasper B. Sanfilippo, Jr. became CEO, and Frank Pellegrino was appointed President and CFO. Pellegrino's new compensation includes a base salary of $700,000, a 100% target bonus, and equity awards totaling $1.35 million for fiscal 2027.

• · The transition was previously disclosed in a July 16, 2026 8-K filing.
• · Pellegrino's severance benefits are either one times or two times the sum of salary and target bonus, contingent on termination without cause or for Good Reason.
• · The Employment Letter includes customary releases and restrictive covenants for severance/equity acceleration.

02-10-2026

Nocopi Technologies' COO Terry Stovold resigned effective October 1, 2026, transitioning to a limited non-executive role through July 1, 2029, with monthly compensation of $8,000 and a $90,000 lump-sum payment upon completion. The company expects to fill the vacancy but has not yet appointed a successor, and the departure is part of a planned transition.

• · Transition period runs from October 1, 2026 to July 1, 2029.
• · Non-compete and non-solicitation obligations extended through July 1, 2031.
• · Employment agreement dated April 1, 2011 remains in effect except as modified.
• · Successor to COO position has not been formally appointed as of filing date.

02-10-2026

Voya Financial announced an executive leadership change: Santhosh Keshavan, currently Chief Technology and Operations Officer, will become Chief Risk and Global Operating Officer effective January 1, 2027. Rajat Kalia will succeed him as Chief Technology Officer. The filing does not disclose any financial figures or performance metrics.

• · The effective date of the role changes is January 1, 2027.
• · Mr. Keshavan's new role is explicitly not that of the principal operating officer under Item 5.02 of Form 8-K.

02-10-2026

Grove Collaborative Holdings appointed Flip van den Bosch as principal financial officer and principal accounting officer effective October 1, 2026. The appointment includes a $25,000 cash retention bonus payable if he remains through May 15, 2027, an annual base salary increase to $261,397, and a grant of 30,000 restricted stock units vesting in two tranches in 2027. The filing does not disclose any financial results or performance metrics, so no positive or negative trends are available.

• · Mr. van den Bosch, age 38, has served as Controller since March 2025 and previously worked at PwC from September 2012 to October 2022, including as senior manager from July 2020.
• · He holds a Master of Laws (LLM) in Tax Law and a Master of Science in Economics from Radboud University and is a CPA.
• · No family relationships or reportable transactions exist between Mr. van den Bosch and the company's directors or officers.

02-10-2026

Freddie Mac announced the departure of Anil Hinduja as Executive Vice President and Chief Risk Officer, effective October 1, 2026. John Glessner, previously Executive Vice President – Investments and Capital Markets, has assumed the role of Chief Risk Officer with no change in compensation. This is a routine executive succession event with no financial impact disclosed.

• · Anil Hinduja's employment ended effective October 1, 2026.
• · John Glessner assumed the role of Executive Vice President and Chief Risk Officer effective October 1, 2026.
• · No change to Mr. Glessner's compensation in connection with the new role.

02-10-2026

EQT Exeter Real Estate Income Trust, Inc. announced the resignation of CFO and board member J. Peter Lloyd, effective September 30, 2026, with no disagreement cited. The board appointed Danielle Domzalski as interim Principal Financial Officer and Jake Sauerteig as a director, both effective October 1, 2026. The changes are routine officer/director transitions with no disclosed financial impact.

• · Danielle Domzalski has been Vice President since August 2026 and Managing Director, CFO Office of EQT Real Estate since January 2026.
• · Jake Sauerteig has served as Chief Operating Officer since May 2025 and Managing Director of Fund Operations and Investor Relations since September 2022.
• · Sauerteig previously helped raise approximately $300 million in equity for 15 private real estate vehicles and over $1 billion in equity for two interval funds.
• · Domzalski is a CFA Charterholder with an MBA from the University of Maryland.
• · Both new appointees have indemnification agreements with the company.

02-10-2026

On September 28, 2026, Michael Farello resigned from the Board of Directors of Better Home & Finance Holding Company, effective immediately. The resignation was not due to any disagreement with the company regarding its operations, policies, or practices. No financial figures or performance metrics were disclosed in this filing.

• · Michael Farello's resignation was effective immediately on September 28, 2026.
• · The resignation was not the result of any disagreement with the company.

02-10-2026

HF Foods Group Inc. entered into amended employment agreements with CEO Felix Lin, CFO Paul McGarry, and CAO Christine Chang, and approved amendments to its severance plan and equity award agreements. The changes enhance severance benefits for the CEO (including target bonus in severance and non-renewal as a qualifying termination), extend the change-in-control protection period from 12 to 24 months, and modify vesting dates and acceleration provisions. No financial figures or performance metrics were disclosed in this filing.

• · The CEO Employment Agreement Amendment makes non-renewal by the company a qualifying termination entitling Mr. Lin to severance benefits.
• · The pro-rata current year bonus eligibility date for the CEO in case of qualifying termination changed from June 30 to March 31.
• · CFO and CAO agreements have an initial term of one year and otherwise mirror the CEO agreement terms.
• · Equity Award Amendments modify RSU/PSU vesting date from April 15 to March 17.
• · Change-in-control protection period increased from 12 months to 24 months.
• · Full acceleration of unvested awards upon death or disability is provided.
• · Pro-rata PSU payment at end of performance period based on actual performance upon qualifying non-change-in-control termination.

02-10-2026

On September 30, 2026, Dr. Constance Hoefer resigned as Chief Scientific Officer of OSR Health, Inc., effective immediately. The resignation was not due to any dispute or disagreement with the company. No replacement or compensatory arrangements were disclosed.

• · Dr. Hoefer's resignation was effective immediately on September 30, 2026.
• · The resignation was not the result of any dispute or disagreement with the company.

02-10-2026

Professional Diversity Network, Inc. (IPDN) announced on October 2, 2026, that the Board decided not to renew CEO Xun Wu's appointment, effective July 22, 2026, with no disagreement related to operations, policies, or practices. The Board appointed CFO Yiran Gu as the new CEO, effective October 2, 2026, while she continues as CFO. Ms. Gu's employment agreement provides $300,000 annual base compensation for a 12-month term, with no negative or declining financial metrics reported in this filing.

• · Ms. Gu has served as CFO since August 2025 and was previously director and chief strategy officer at Koala Malta Limited from July 2021 to August 2025.
• · The Employment Agreement is effective October 2, 2026, with a 12-month term, and supersedes the prior employment agreement dated August 8, 2025.
• · Ms. Gu may terminate employment upon material reduction in authority, duties, responsibilities, or annual compensation; the Company may terminate for cause, death, or disability.
• · The agreement includes customary confidentiality, non-disclosure, conflicts-of-interest, non-solicitation, and other restrictive covenants.
• · Ms. Gu has no family relationships with directors or executive officers and is not party to any transaction requiring disclosure under Item 404(a).

02-10-2026

Cingulate Inc. filed an 8-K on October 2, 2026, disclosing an amendment to the employment agreement of Matthew N. Brams, EVP and Chief Medical Officer, extending his full-time trial period from September 30, 2026 to December 31, 2026. The amendment was effective September 30, 2026, and is filed as Exhibit 10.1. No financial impact or other material changes were disclosed.

• · Amendment No. 2 to Employment Agreement effective September 30, 2026
• · Trial period extended from September 30, 2026 to December 31, 2026
• · Exhibit 10.1 filed with the 8-K

02-10-2026

On October 1, 2026, Jennifer Johnson, EVP and Chief Administrative Officer of Aimco, resigned for 'Good Reason' due to diminished responsibilities following the shareholder-approved Plan of Sale and Liquidation. She will receive severance benefits and provide limited consulting services until May 2, 2027, at $750 per hour for up to 10 hours per month. The resignation is tied to a Change in Control under the company's Executive Severance Policy.

• · The resignation is effective November 1, 2026.
• · Consulting arrangement runs until May 2, 2027, terminable by either party with 30 days' notice.
• · The Plan of Sale and Liquidation was approved by shareholders on February 6, 2026.
• · Ms. Johnson will receive payments under the Executive Severance Policy, a cash award letter agreement dated April 16, 2026, and applicable equity award agreements.

02-10-2026

Starfighters Space, Inc. approved significant compensation increases for its CEO and CFO on September 28, 2026. CEO Tim Franta's base salary was raised from $108,000 to $350,000 (a 224% increase) with a maximum annual bonus of up to 50% of the new salary, while CFO David Whitney's salary increased from $180,000 to $300,000 (a 67% increase) with a maximum bonus of up to 30%. The company also authorized back-pay for both executives to retroactively apply the new salaries from earlier dates in 2026. The compensation adjustments reflect the company's efforts to retain key leadership, though the substantial increases may raise questions about cost discipline.

• · Back-pay for CEO Tim Franta covers the period from March 1, 2026 through September 28, 2026.
• · Back-pay for CFO David Whitney covers the period from June 24, 2026 through September 28, 2026.
• · Any bonus portion exceeding $75,000 is paid 65% in cash and 35% in RSUs, with RSUs vesting equally over three years.

02-10-2026

Broadway Financial Corporation announced the resignation of John Allen, Executive Vice President and Chief Banking Officer, effective December 31, 2026. Mr. Allen will serve in a transition capacity until that date. The company will evaluate the position's structure and responsibilities before deciding on next steps, including a potential search for a successor.

• · Resignation effective date: December 31, 2026
• · Transition period through December 31, 2026
• · Company will evaluate position structure, scope, and responsibilities before determining next steps

02-10-2026

PROCEPT BioRobotics Corp (PRCT) announced the appointment of Dr. Michael Mack as an independent Class II director, effective October 2, 2026, expanding the board from nine to ten members. Dr. Mack, a renowned cardiac surgeon with extensive leadership experience, will serve until the 2029 annual meeting and receive standard non-employee director compensation. No financial impact or performance metrics were disclosed in this filing.

• · Dr. Mack's initial term expires at the 2029 annual meeting of stockholders.
• · Dr. Mack is board-certified in internal medicine, general surgery, and thoracic surgery.
• · Dr. Mack has practiced in Dallas, Texas since 1982.
• · Dr. Mack serves as Chairman of the Board of the Baylor Scott & White Research Institute and Associate Academic Officer of Baylor Scott & White Health.
• · Dr. Mack is Chair of the American Board of Thoracic Surgery, Co-Chair of the FDA Heart Valve Collaboratory, and Senior Vice Chair of the NIH's Cardiothoracic Surgical Trials Network.
• · Dr. Mack's prior leadership roles include President of the Society of Thoracic Surgeons (2011), President of the Thoracic Surgery Foundation for Research and Education (2009-2011), President of the Southern Thoracic Surgical Association (2009), and President of the International Society for Minimally Invasive Cardiothoracic Surgery (2000).
• · Dr. Mack earned his medical degree from Saint Louis University and completed residencies at the University of Minnesota and the University of Texas Southwestern Medical Center.
• · Dr. Mack will enter into the Company's standard director and officer indemnification and advancement agreement.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K were identified.

02-10-2026

Verra Mobility appointed Jon Newhard as President and CEO effective November 1, 2026, succeeding interim CEO Jon Keyser. Newhard brings over 20 years of transportation and mobility leadership, most recently as CEO of Yunex Traffic GmbH. The outgoing interim CEO will remain in an advisory capacity to ensure a smooth transition.

02-10-2026

Leef Brands Inc. appointed Hirsh Jain as an independent director, replacing Kevin Wilson who resigned from the board but remains CFO. The move increases independent director representation to a 3-of-5 majority and ensures fully independent Audit and Compensation Committees, aligning governance with major U.S. exchange standards. The change is part of Leef's preparation for potential interstate commerce and international export opportunities, though no financial impact or performance metrics were disclosed.

• · Leef has filed DEA registration applications across its California and Nevada licenses.
• · The company is building relationships in key international markets and preparing operations to meet destination-market standards.
• · Hirsh Jain holds a B.A. from UC Berkeley and a J.D. from Harvard Law School.
• · Prior to cannabis, Jain served as Director of Government Affairs at Airbnb and Engagement Manager at McKinsey & Company.

02-10-2026

KinderCare announced that Mike Nuzzo resigned from the Board of Directors effective September 29, 2026, due to personal and professional time commitments. David Barse, who joined the Board on August 3, 2026, will replace Nuzzo as Head of the Audit Committee, and Preston Grasty, Senior Investment Leader at Partners Group, will rejoin the Board effective September 29. The company expressed gratitude for Nuzzo's service and welcomed Grasty's return.

• · David Barse joined the Board on August 3, 2026.
• · Preston Grasty is a Senior Investment Leader at Partners Group.
• · KinderCare is headquartered in Lake Oswego, Oregon.
• · KinderCare provides child care benefits in partnership with employers, including on-site care, tuition benefits, and backup care.

02-10-2026

On October 1, 2026, Steven E. Rodgers, a Class II independent director of Aveanna Healthcare Holdings, Inc., resigned from the Board of Directors effective immediately. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices. Mr. Rodgers previously served on the Audit Committee and the Compensation Committee.

• · Mr. Rodgers' resignation was effective immediately as of October 1, 2026.
• · The resignation was not due to any disagreement with the Company on operations, policies, or practices.
• · Mr. Rodgers served on both the Audit Committee and the Compensation Committee prior to his resignation.

02-10-2026

Live Nation Entertainment entered into an amended employment agreement with CEO Michael Rapino, extending his term through December 31, 2031. The agreement maintains his $3M base salary and $17M target cash bonus, while introducing new annual equity grants totaling $40M (including $15M in time-based RSUs and $15M in performance-based PSUs tied to relative TSR). The compensation structure is 70% performance-based, 25% time-based equity, and 5% guaranteed salary. While the agreement provides retention stability, the heavy reliance on performance metrics (including a 0% payout if TSR falls below the 25th percentile) introduces significant variability in realized compensation.

• · The Employment Agreement is effective October 1, 2026 and ends December 31, 2031.
• · The existing employment agreement continues to govern Mr. Rapino's 2026 annual cash bonus, performance-based equity award, and prior equity awards.
• · Annual Time-Based RSU Awards vest 20% per year over five years.
• · Annual PSU Awards have a three-year performance period based on relative TSR vs S&P 500, with vesting at the end of the period.
• · Upfront RSUs vest 40% on first anniversary, then 20%, 20%, 10%, 10% over five years.
• · Severance on termination without cause or for good reason includes 2x (base salary + most recent bonus + most recent Annual Performance Shares) plus full equity acceleration (PSUs at target).
• · Severance on death or disability includes 1x (base salary + most recent bonus) plus full equity acceleration (PSUs at target).
• · Non-renewal by CEO (with notice by June 30, 2031) allows continued vesting of existing equity but no cash severance.
• · Non-renewal by Company or mutual failure to agree results in full vesting of all unvested equity and PSUs at target for 2030 and 2031 grants.
• · Change in control triggers full vesting of all equity, with PSUs measured through the change in control date.

02-10-2026

On September 30, 2026, RTB Digital, Inc. (Nasdaq: RTB) appointed Mary Elizabeth Truss, former Prime Minister of the United Kingdom, as a director. Ms. Truss will receive an annual equity award of $150,000 in restricted stock units (RSUs), prorated for the remaining 2026 service period, vesting on December 31 of the applicable year. The appointment reflects the company's strategy to leverage her international business, government, and media experience for its enterprise media operating system.

• · Ms. Truss served as the 56th Prime Minister of the United Kingdom and was Conservative MP for South West Norfolk from 2010 to 2024.
• · She held six Cabinet-level roles including Foreign Secretary, Secretary of State for International Trade, and Lord Chancellor.
• · Her book 'Ten Years to Save the West' was a Sunday Times best-seller published in April 2024.
• · The RSU award vests in full on December 31 of the applicable calendar year, subject to continued service.
• · No family relationships or material interests in transactions were reported under Item 404(a) of Regulation S-K.

02-10-2026

Pinterest amended its Severance and Change in Control Plan for Level 21 employees, effective September 30, 2026. The amendment adds pro-rated target bonus entitlements for non-CIC terminations without cause and enhanced bonus provisions for CIC-related terminations, while also revising the definition of 'good reason' to include a >10% reduction in target annual bonus. The changes are incremental and apply to a specific employee level, with no financial impact disclosed.

• · The Plan applies to employees in job category position Level 21 only.
• · Performance-based restricted stock units remain subject to existing award agreement terms.
• · Single trigger acceleration of equity awards applies only if awards are not assumed, substituted, continued, or replaced in a change in control.
• · The amendment was filed as an exhibit to Pinterest's 2025 Annual Report on Form 10-K (filed Feb 12, 2026).

02-10-2026

Richtech Robotics Inc. held its 2026 Annual Meeting of Stockholders on September 29, 2026, where shareholders elected Saul Factor and John Shigley to three-year board terms and ratified CBIZ CPAs P.C. as the independent auditor. Both proposals passed with overwhelming support, with director elections receiving over 389 million votes for each nominee and auditor ratification receiving over 405 million votes for. No negative or declining metrics were reported.

• · Saul Factor received 389,423,507 votes for and 16,833,265 withheld, with 100 broker non-votes.
• · John Shigley received 401,733,521 votes for and 4,523,251 withheld, with no broker non-votes.
• · Auditor ratification received 405,557,046 votes for, 589,622 against, and 110,104 abstentions.
• · The company is an emerging growth company and has not elected to use the extended transition period for new accounting standards.
• · The company's Class B Common Stock is listed on Nasdaq under the symbol RR.

02-10-2026

CNS Pharmaceuticals held its 2026 Annual Meeting on September 30, 2026, with a quorum of 45.72% (668,188 of 1,461,449 shares). Stockholders approved all five proposals: election of six directors, ratification of MaloneBailey as auditor, advisory approval of executive compensation, an amendment to the 2020 Equity Plan increasing authorized shares by 650,000 (to 765,061 total), and authorization to adjourn if needed. While all proposals passed, the advisory vote on executive compensation received only 93.3% support from votes cast (excluding broker non-votes), and the equity plan amendment received 92.2% support, indicating some shareholder dissent.

• · The meeting was held at 12:00 p.m. ET on September 30, 2026.
• · Record date for the meeting was August 10, 2026.
• · Broker non-votes were 563,072 on all director elections and proposals 3 and 4, indicating a significant portion of shares were held by brokers without voting instructions.
• · Proposal 5 (adjournment authorization) passed with 622,421 votes for, 45,635 against, and 132 abstain.
• · The 2020 Plan amendment was approved with 96,953 for, 8,128 against, and 35 abstain (excluding broker non-votes).

02-10-2026

Celcuity Inc. appointed David W. Gryska to its Board of Directors, effective October 2, 2026. Mr. Gryska brings over 35 years of strategic and financial leadership in life sciences, having served as CFO of Incyte and Celgene, and as a board member of eight public biotech companies. The appointment comes as Celcuity transitions to a commercial-stage company following its first FDA approval for REVTORPYK (gedatolisib) in advanced breast cancer.

• · Mr. Gryska holds a B.A. in Accounting and Finance from Loyola University and an MBA from Golden Gate University.
• · He previously served as a partner at Ernst & Young LLP in California.
• · Celcuity's Phase 3 trial VIKTORIA-2 includes two independent studies in treatment-naive advanced breast cancer patients.
• · A Phase 1b/2 trial (CELC-G-201) is evaluating gedatolisib with darolutamide in metastatic castration-resistant prostate cancer.

02-10-2026

The Gorman-Rupp Company entered into new Change of Control Severance Agreements with its CEO Scott A. King, EVP Brigette A. Burnell, and CFO Ronald F. Stoops on October 1, 2026. The agreements provide enhanced severance benefits, including lump-sum payments of up to 3x salary plus bonus for the CEO and 2x for other executives, COBRA coverage, retirement service credits, and accelerated equity vesting upon a qualifying termination following a change of control. The agreements include a 'best pay' provision but no tax gross-up, and have an initial one-year term with automatic renewal.

• · Severance agreements have an initial term of one year with a one-year evergreen renewal period.
• · CEO severance: lump-sum payment equal to 3 times (annual base salary + Prior Bonus Amount) plus Prorated Annual Bonus.
• · Other executive officers: lump-sum payment equal to 2 times (annual base salary + Prior Bonus Amount) plus Prorated Annual Bonus.
• · COBRA premium coverage provided for 18 months as a lump-sum payment.
• · Additional 24 months of credited service under qualified and supplemental retirement plans.
• · Accelerated vesting of time-based equity awards and performance-based awards upon qualifying termination after a change of control.
• · No tax gross-up; includes a 'best pay' provision to reduce payments if it results in a higher after-tax amount for the executive.
• · Severance benefits conditioned on execution and non-revocation of a release of claims.

02-10-2026

First Community Corp (FCCO) disclosed a consulting agreement with retiring EVP and Chief Banking Officer J. Ted Nissen, effective September 30, 2026, following his previously announced retirement from all officer and board positions effective December 31, 2026. The agreement provides monthly consulting fees of $40,000 for January–March 2027 and $15,000 for April–December 2027, with standard confidentiality and work-product provisions. No financial impact or performance metrics were disclosed, and the filing is limited to this executive transition.

• · Consulting agreement entered into on September 30, 2026
• · Nissen will report to the Bank's CEO and work with the Company's President and CEO
• · Payments begin January 15, 2027, prorated for partial months
• · Lump sum for earned but unpaid amounts due within 60 days after termination
• · Agreement includes customary confidentiality, work product and return-of-property provisions
• · Full agreement to be filed as exhibit to Q3 2026 Form 10-Q

02-10-2026

Hub Group, Inc. (HUBG) filed an 8-K on October 2, 2026, disclosing that on October 1, 2026, a majority of stockholders approved by written consent the removal of three directors (Michael Flannery, Peter McNitt, Gary Yablon), the adoption of Second Amended and Restated Bylaws, and the appointment of four new directors (Thaddeus J. Malik, Thomas P. Fitzgerald, Thomas M. White, Gregory D. Bunch). The action reflects a significant board shakeup, but the filing provides no financial impact or operational performance data.

• · Written consent executed by stockholders holding a majority in power of shares on October 1, 2026.
• · Notice under Section 228(e) of the DGCL sent on or about October 2, 2026.
• · Company's Amended and Restated Certificate of Incorporation and DGCL govern the written consent action.